-
Z-WEHD-FMK in Caspase-1 Pyroptosis Research
2026-09-12
Z-WEHD-FMK is a cell-permeable, irreversible inhibitor for separating inflammatory caspase activity from downstream pyroptosis, apoptosis, and pathogen-driven remodeling. This workflow-focused guide connects caspase-1 regulation in lung cancer with practical Chlamydia and cell-signaling assays while emphasizing controls, dosing, and interpretation.
-
Wnt/NR2F2/GPX4 in Platinum-Resistant Brain Metastasis
2026-09-11
This study identifies a redox adaptation in lung cancer-derived brain metastases in which GPX4 and GSTM1 drive high glutathione consumption, suppress ferroptosis, and reduce platinum sensitivity. Its integrated metabolic, proteomic, functional, and transcriptional analyses connect Wnt/NR2F2 signaling to GPX4 regulation and suggest that GPX4 inhibition may help restore platinum activity.
-
Toremifene: An Assay Strategy for Prostate Cancer
2026-09-11
Toremifene is a selective estrogen-receptor modulator for dissecting hormone-responsive prostate cancer biology. This article presents an assay framework that separates estrogen-receptor effects from the STIM1–TSPAN18 calcium-signaling axis implicated in bone metastasis.
-
Mitochondrial Transfer in Orofacial Inflammatory Pain
2026-09-10
Li et al. show that satellite glial cells protect trigeminal neurons during acute orofacial inflammation by transferring functional mitochondria through tunneling nanotubes and extracellular uptake. The study connects this transfer to ATL1-dependent ER remodeling, restored mitophagy, improved calcium homeostasis, and reduced neuronal hyperexcitability, identifying mitochondria–ER contacts as a mechanistic target for pain research.
-
Bile Acid Subtypes and Immune Dysfunction in CRC
2026-09-10
Feng et al. used bile acid metabolism-based transcriptomic clustering to define colorectal cancer subtypes associated with survival, immune-cell infiltration, and predicted immunotherapy response. The study prioritizes CLCA1, UGT2A3, and ZG16 as reproducible expression markers, while showing that CLCA1 has the clearest prognostic association.
-
Omeprazole: Practical H+,K+-ATPase Workflow
2026-09-09
Omeprazole provides a defined H+,K+-ATPase inhibition reference for gastric acid secretion research and related antiulcer assay workflows. This article covers handling, assay setup, and QC using product-dossier values; it should not be used as clinical, diagnostic, or therapeutic guidance.
-
Phebestin Antiplasmodial Activity and MAP Inhibition
2026-09-09
The reference study identifies phebestin, a bestatin-related aminopeptidase inhibitor, as a nanomolar inhibitor of both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. Its stage-spanning activity, persistent effects after washout, target-oriented in silico analysis, and efficacy in two murine malaria models make it a useful lead for aminopeptidase-focused antimalarial research, while important translational limitations remain.
-
Ratiometric Imaging of Amyloid-β Fibrils with Ru(II)
2026-09-08
The 2024 study developed dual-emissive tris-heteroleptic ruthenium complexes that report amyloid-β aggregation through an internal fluorescence–phosphorescence ratio and enable confocal imaging of fibrils. Complex 2 showed a stronger response to Aβ40 than Aβ42, illustrating how ligand design, photophysical readouts, and molecular modeling can be combined in an amyloid fibril formation study.
-
Q-VD-OPh in Anastasis and Caspase-Controlled Assays
2026-09-07
Q-VD-OPh is a cell-permeable pan-caspase inhibitor that can do more than suppress apoptosis. This guide explains how to use it as a temporal control for distinguishing caspase activation, irreversible cell death, and post-caspase recovery in advanced apoptosis research.
-
Bestatin (Ubenimex) Research Workflows
2026-09-07
Bestatin (Ubenimex) provides a practical way to perturb aminopeptidase-dependent biology across purified-enzyme assays, cancer research, apoptosis assay design, and multidrug resistance (MDR) research. This guide connects its concentration-dependent selectivity with reproducible stock preparation, cell-based validation, and structure-guided follow-up experiments.
-
Amyloid Beta-Peptide (1-40): Aβ40 Translation
2026-09-05
A mechanistic and translational framework for using human Aβ40 to connect aggregation state, calcium-dependent membrane interactions, surface-resolved spectroscopy, and reproducible Alzheimer’s disease research workflows.
-
17-AAG (Tanespimycin): HSP90 Research Guide
2026-09-04
17-AAG, also called Tanespimycin, is a synthetic geldanamycin analogue that inhibits the HSP90 chaperone and destabilizes oncogenic client proteins. Product data report nanomolar activity in cancer-cell assays, antitumor effects in xenograft models, and solvent-dependent handling requirements for research use.
-
BQCA and the Next Generation of M1 Signaling
2026-09-04
Benzyl Quinolone Carboxylic Acid (BQCA) offers translational researchers a way to interrogate M1 muscarinic receptor signaling without treating receptor activation as a single, uniform event. By enhancing acetylcholine responsiveness, BQCA helps connect receptor pharmacology with GRK-dependent pathway selection, neuronal activity, and cognitive disease models. This article examines the mechanistic rationale, experimental design principles, competitive advantages, and limitations that should guide responsible use of BQCA in Alzheimer’s disease research and broader cognitive function modulation programs.
-
ABT-888 (Veliparib) for DNA Repair Studies
2026-09-03
ABT-888 (Veliparib) provides a practical way to test PARP1/2-dependent DNA repair inhibition and chemotherapy or radiation sensitization. This guide connects colorectal cancer and microsatellite instability models with biomarker-led assay design, while highlighting why PARP combinations should be validated rather than assumed in leukemia ADC studies.
-
U0126-EtOH: MEK1/2 Inhibitor Workflow Guide
2026-09-03
U0126-EtOH is a practical MEK1/2 inhibitor for separating ERK1/2-driven stress responses from parallel MAPK programs. This guide translates its use into reproducible neuronal, leukemia, and inflammation workflows while emphasizing controls, dosing discipline, and troubleshooting.